Eggschain Secures First Patent for Tracking Genetic Material via Blockchain
Eggschain Secures First Patent for Tracking Genetic Material via Blockchain Patented Chain of Custody Solution will Improve Fertility and IVF Processes by Securing Healthcare Data for Sperm, Eggs, Embryos, DNA, Blood, and Genomes
AUSTIN, Texas — July 15, 2021
Eggschain, a healthcare technology company that combines genetics and
blockchain to track genetic material, today announced its pioneering, patented
solution for tracking and tracing the storage and transfer of blood, genome,
tissues, organs, DNA, RNA, sperm, eggs, embryos, and other biospecimens. This
new supply chain solution aims to provide a universal tracing and tracking
platform to deliver peace of mind for people and families undergoing IVF, and
the professionals who until now have relied on a high-touch, low-tech approach
that is arduous and inconsistent. Eggschain’s technology provides newfound
clarity and thorough insight for medical professionals into the supply chain,
from initial donation to testing, transfer and storage of the biospecimen.
Eggschain is the first patented blockchain-based biospecimen management and
monitoring system that makes the IVF process more stable, transparent, and
trackable for patients. This system maintains the confidentiality of patients’
personal information and allows clinics to securely and safely track the
locations of biological specimens through a digital chain of custody. This
allows for complete transparency and integrity during the process of IVF and
prevents life altering mistakes such as supply loss and wrongful billing of
patients. Eggschain’s provenance technology will be used by fertility clinics,
hospitals, cryogenic centers, and medical labs for screening genetic material.
“The technology such as developed by Eggschain has not existed before in the
field of reproductive medicine. Blockchain is an incredibly powerful
technology that allows for secure recording and tracking of data, and the
implications for medical data and specimens are tremendous,” said Hugh S.
Taylor, MD, Chair of Obstetrics, Gynecology and Reproductive Sciences at Yale
University. “With infertility increasing globally along with the ability to
store biological materials, Eggschain will enable patients to monitor and
follow their biologic specimens. Eggschain provides secure and safe tracking
of embryos, eggs and sperm, so that their location and integrity are always
confidently verified and easily assured.”
Eggschain is a female-founded and -owned company created by Wei Escala, a
software engineer whose passion for women’s health drove her to develop a
secure platform to provide transparency and peace of mind for people and
families undergoing the emotional and physical demands of IVF. As CEO of
Eggschain, Wei has built an all-star team of collaborators comprising
technologists, business leaders, physicians and scientists, with a focus on
continuing to develop game-changing innovation for patients, doctors, clinics
and labs through the Eggschain platform.
“Our eggs, sperm, organs and other biospecimens are uniquely personal and
therefore precious, yet until now the average person hasn’t had a consistent
and secure way to track location and movement. Even clinics and labs have
lacked a universal tracking mechanism, creating unnecessary paperwork and
leaving room for human error,” said Wei Escala, CEO and founder of Eggschain.
“Eggschain uses the first patented blockchain technology to bring professional
grade information and data to the individual in a convenient and secure
format, and also simplifies and improves the tracking process for labs,
ensuring they are secure and inspection-ready.”
Eggschain uses the Stacks blockchain, which allows people to build
decentralized applications for Bitcoin, to secure genetic data in an immutable
and transparent fashion. This powerful solution to genetic materials tracking
helps healthcare professionals maintain a thorough record of the journey each
biospecimen has taken and helps mitigate any possible mix ups.
Eggschain recently joined a cohort of 25 blockchain developers being supported
by The Stacks Foundation through the Stacks Accelerator Program. The
intensive three-month program is backed by a leading coalition of Stacks
partners, including the Stacks Foundation, Hiro Systems, Freehold, and Daemon
Technologies, which have committed an initial $4M USD to support more than one
hundred early-stage crypto technology entrepreneurs with funding, mentorship,
and access to the incredible community of Stacks developers.
For further information about Eggschain, please visit https://eggschain.com/.
About Eggschain, INC.
Eggschain is a healthcare technology company and thought leader in the
fertility, health tech, family-building and cryogenic preservation industries.
Patent-granted and cloud-based, Eggschain is the first blockchain-integrated
inventory management and chain of custody technology for tracking bio
specimens, including sperm, eggs, embryos, genome, stem cell, tissues and
organs, and other genetic material. In partnership with several of the world’s
leading experts in reproductive biology, endocrinology and high complexity
labs, Eggschain delivers medical grade information and data to individuals
undergoing IVF in a secure, transparent and universally trackable format, and
also provides the means for clinics to monitor their inventory, either
personal, such as oocytes and sperm, or lab-related, including equipment
inventory and maintenance scheduling. At its core, Eggschain strives to enable
better decision-making, preserving the hope of life and helping to advance
Secure smart contracts and apps for Bitcoin. The Stacks ecosystem is a
collection of independent entities, developers, and community members working
to build a user-owned internet on Bitcoin. The Stacks 2.0 blockchain extends
the design of Bitcoin to enable secure apps and predictable Clarity smart
contracts without modifying Bitcoin itself, opening innovation on the network
for the first time. The Stacks cryptocurrency (STX) is used as fuel for
networking activity and contract execution and can be locked by STX holders
via ‘Stacking’ to earn Bitcoin (BTC) rewards for supporting blockchain
consensus. Stacks cryptocurrency was distributed to the general public through
the first-ever SEC qualified token offering in US history.
View source version on businesswire.com:
Alex Broudy / firstname.lastname@example.org